基于Crisper cas9基因编辑技术的发展及前景
摘要
关键词
全文:
PDF (English)参考
JIANG F, DOUDNA J A. CRISPR-Cas9 Structures and Mechanisms[J]. Annual review of biophysics, 2017(01): 505-529.
HRYHOROWICZ M, LIPIŃSKI D, ZEYLAND J, et al. CRISPR/Cas9 Immune System as a Tool for Genome Engineering[J]. Archivum Immunologiae et Therapiae Experimentalis, 2016(03): 233-240.
HSU P D, LANDER E S, ZHANG F. Development and Applications of CRISPR-Cas9 for Genome Engineering[J]. Cell, 2014(06):
-1278.
ZHANG C, QUAN R, WANG J. Development and application of CRISPR/Cas9 technologies in genomic editing[J]. Human Molecular Genetics, 2018(R2): 79-88.
HRYHOROWICZ M, LIPIŃSKI D, ZEYLAND J, et al. CRISPR/Cas9 Immune System as a Tool for Genome Engineering[J]. Archivum Immunologiae et Therapiae Experimentalis, 2016(03): 233-240.
LIANG P, XU Y, ZHANG X, et al. CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes[J]. Protein & Cell, 2015(05): 363-372.
REDMAN M, KING A, WATSON C, et al. What is CRISPR/Cas9?[J]. Archives of disease in childhood - Education & practice edition, 2016(04): 213-215.
TORRES-RUIZ R, RODRIGUEZ-PERALES S. CRISPR-Cas9 technology: applications and human disease modelling[J]. Brief Funct Genomics, 2017(01): 4-12.
KARLGREN M, SIMOFF I, KEISER M, et al. CRISPR-Cas9: A New Addition to the Drug Metabolism and Disposition Tool Box[J]. Drug Metab Dispos, 2018(11): 1776-1786.
DOI: http://dx.doi.org/10.26549/yzlcyxzz.v3i8.6249
Refbacks
- 当前没有refback。
此作品已接受知识共享署名-非商业性使用 4.0国际许可协议的许可。